Despite advancements in melanoma therapy, the prognosis remains unfavorable for many patients. The proteasome inhibitor MG132 has shown therapeutic potential through pathway regulation, yet its ...

NYOH joins OneOncology to leverage its patient-first culture and advanced technology solutions, enhancing cancer care delivery and practice growth. The partnership supports NYOH's expansion, including ...

Innovative imaging with Phenocycler 2.0 enables detailed study of mouse bone marrow, paving the way for improved therapies ...

A new bone marrow imaging technique could change treatment for cancer, autoimmune disease and musculoskeletal disorders.

Indiana University School of Medicine scientists have developed a powerful new imaging technique to study bone marrow in ...

School of Medicine has announced scientists have developed a “powerful” new imaging technique to study bone marrow in mouse ...

Beckman Coulter Life Sciences, a Danaher company and a global leader in laboratory automation and innovation, announces the ...

Q1 2025 Earnings Call Transcript April 22, 2025 Danaher Corporation beats earnings expectations. Reported EPS is $1.88, ...

Danaher Corporation’s DHR share price has surged by 6.12%, which has investors questioning if this is right time to sell.

DHR's first-quarter earnings are likely to have been aided by strength in the Biotechnology segment. However, weakness in the ...